Td Asset Management Inc Ptc Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$18.07 - $29.37 $220,454 - $358,314	-12,200 Reduced 20.65%	46,874 $1.29 Million
Q3 2023 Oct 27, 2023	SELL	$22.41 - $41.99 $169,486 - $317,570	-7,563 Reduced 11.35%	59,074 $1.32 Million
Q2 2023 Aug 09, 2023	BUY	$40.4 - $59.1 $1.07 Million - $1.56 Million	26,386 Added 65.55%	66,637 $2.71 Million
Q1 2023 May 10, 2023	BUY	$38.16 - $48.86 $814,868 - $1.04 Million	21,354 Added 113.0%	40,251 $1.95 Million
Q4 2022 Feb 06, 2023	SELL	$33.53 - $54.79 $446,485 - $729,583	-13,316 Reduced 41.34%	18,897 $721,000
Q3 2022 Nov 07, 2022	BUY	$41.85 - $53.85 $37,665 - $48,465	900 Added 2.87%	32,213 $1.62 Million
Q2 2022 Aug 04, 2022	SELL	$25.6 - $45.23 $122,905 - $217,149	-4,801 Reduced 13.29%	31,313 $1.25 Million
Q1 2022 May 10, 2022	SELL	$33.33 - $44.6 $343,965 - $460,272	-10,320 Reduced 22.23%	36,114 $1.35 Million
Q4 2021 Feb 10, 2022	BUY	$35.36 - $41.86 $159,756 - $189,123	4,518 Added 10.78%	46,434 $1.85 Million
Q2 2021 Aug 11, 2021	SELL	$37.95 - $49.37 $71,687 - $93,259	-1,889 Reduced 4.31%	41,916 $1.61 Million
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $93,600 - $137,840	2,000 Added 4.78%	43,805 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $110,643 - $156,045	2,307 Added 5.84%	41,805 $2.55 Million
Q3 2020 Nov 10, 2020	SELL	$45.41 - $57.07 $86,279 - $108,433	-1,900 Reduced 4.59%	39,498 $1.85 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $493,696 - $637,768	11,600 Added 38.93%	41,398 $2.1 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $1.61 Million - $2.96 Million	-49,833 Reduced 62.58%	29,798 $1.33 Million
Q4 2019 Feb 11, 2020	SELL	$32.22 - $50.07 $97,465 - $151,461	-3,025 Reduced 3.66%	79,631 $3.83 Million
Q3 2019 Nov 07, 2019	BUY	$33.82 - $48.17 $21,137 - $30,106	625 Added 0.76%	82,656 $2.8 Million
Q2 2019 Aug 01, 2019	BUY	$35.42 - $45.0 $106,260 - $135,000	3,000 Added 3.8%	82,031 $3.69 Million
Q1 2019 May 08, 2019	BUY	$28.09 - $39.49 $353,934 - $497,574	12,600 Added 18.97%	79,031 $2.98 Million
Q4 2018 Feb 01, 2019	BUY	$29.83 - $46.51 $298,300 - $465,100	10,000 Added 17.72%	66,431 $2.28 Million
Q3 2018 Nov 01, 2018	BUY	$33.9 - $47.77 $1.41 Million - $1.99 Million	41,600 Added 280.49%	56,431 $2.65 Million
Q2 2018 Jul 31, 2018	BUY	$25.7 - $47.88 $381,156 - $710,108	14,831 New	14,831 $500,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$418 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$361 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$356 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$338 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$331 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account